rs376630110
Positions:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PM4_SupportingBP6_ModerateBS2
The NM_012452.3(TNFRSF13B):βc.563_565delβ(p.Lys188del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00081 in 1,614,090 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.00058 ( 0 hom., cov: 32)
Exomes π: 0.00083 ( 17 hom. )
Consequence
TNFRSF13B
NM_012452.3 inframe_deletion
NM_012452.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.75
Genes affected
TNFRSF13B (HGNC:18153): (TNF receptor superfamily member 13B) The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_012452.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 17-16940391-CTCT-C is Benign according to our data. Variant chr17-16940391-CTCT-C is described in ClinVar as [Benign]. Clinvar id is 538716.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-16940391-CTCT-C is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAdExome4 at 17 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFRSF13B | NM_012452.3 | c.563_565del | p.Lys188del | inframe_deletion | 4/5 | ENST00000261652.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFRSF13B | ENST00000261652.7 | c.563_565del | p.Lys188del | inframe_deletion | 4/5 | 1 | NM_012452.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000591 AC: 90AN: 152188Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
90
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00168 AC: 422AN: 250746Hom.: 8 AF XY: 0.00217 AC XY: 294AN XY: 135578
GnomAD3 exomes
AF:
AC:
422
AN:
250746
Hom.:
AF XY:
AC XY:
294
AN XY:
135578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000833 AC: 1218AN: 1461784Hom.: 17 AF XY: 0.00120 AC XY: 873AN XY: 727178
GnomAD4 exome
AF:
AC:
1218
AN:
1461784
Hom.:
AF XY:
AC XY:
873
AN XY:
727178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000584 AC: 89AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74472
GnomAD4 genome
AF:
AC:
89
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
66
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Immunodeficiency, common variable, 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
TNFRSF13B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at